ActiQs / Forskning

PUBLIKATIONSREGISTRET

Gå till forskningen.

Publikationsdata från Europe PMC och PubMed. Följ källhänvisningar från ämnesregistret till originalpublikationerna.

Publikationer som ChEBI hänvisar till för SB 203580. Visa hela publikationsregistret

En publikationsträff är inte en slutsats. Publikationslistan visar bibliografiska uppgifter. Eventuella forskningsutdrag visas separat med originalunderlag. En källhänvisning visar inte i sig effekt, dosering eller säkerhet.

Publikationer i urvalet

29 träffar

Bibliografisk träff 2020-06-04

SB203580 protects against inflammatory response and lung injury in a mouse model of lipopolysaccharide‑induced acute lung injury.

Li G, Dai Y, Tan J, Zou J, Nie X, Yang Z, Zhao J, Yang X, Chen J.

Mol Med Rep · journal article · DOI 10.3892/mmr.2020.11214

Bibliografisk träff 2019-09-01

[P38 MAPK inhibitor SB203580 attenuates the toxicity of ropivacaine on PC12 cells].

Chen Y, Wang E, Sun Z, Song Z, Ye Z, Zhang Z.

Zhong Nan Da Xue Xue Bao Yi Xue Ban · journal article · DOI 10.11817/j.issn.1672-7347.2019.180602

Bibliografisk träff 2019-07-10

Combination of metformin and p38 MAPK inhibitor, SB203580, reduced myocardial ischemia/reperfusion injury in non-obese type 2 diabetic Goto-Kakizaki rats.

Sanit J, Prompunt E, Adulyaritthikul P, Nokkaew N, Mongkolpathumrat P, Kongpol K, Kijtawornrat A, Petchdee S, Barrère-Lemaire S, Kumphune S.

Exp Ther Med · research-article; journal article · DOI 10.3892/etm.2019.7763

Bibliografisk träff 2018-08-09

SB203580 attenuates acute lung injury and inflammation in rats with acute pancreatitis in pregnancy.

Zhou Y, Xia H, Zhao L, Mei F, Li M, You Y, Zhao K, Wang W.

Inflammopharmacology · journal article · DOI 10.1007/s10787-018-0522-9

Bibliografisk träff 2015-11-01

BDNF contributes to angiotensin II-mediated reductions in peak voltage-gated K+ current in cultured CATH.a cells.

Becker BK, Wang HJ, Tian C, Zucker IH.

Physiol Rep · research-article; journal article · DOI 10.14814/phy2.12598

Bibliografisk träff 2015-10-01

Glial activation in the periaqueductal gray promotes descending facilitation of neuropathic pain through the p38 MAPK signaling pathway.

Ni HD, Yao M, Huang B, Xu LS, Zheng Y, Chu YX, Wang HQ, Liu MJ, Xu SJ, Li HB.

J Neurosci Res · research support, non-u.s. gov't; journal article · DOI 10.1002/jnr.23672

Bibliografisk träff 2015-08-01

[Mechanism of continuous venovenous hemofiltration combined with ulinastatin for the treatment of septic shock].

Guo X, Wang Z, Liu Y, Xu Q, Su L, Wu F.

Nan Fang Yi Ke Da Xue Xue Bao · research support, non-u.s. gov't; journal article

Bibliografisk träff 2015-05-01

[Extremely low frequency electromagnetic field induces apoptosis of osteosarcoma cells via oxidative stress].

Yang ML, Ye ZM.

Zhejiang Da Xue Xue Bao Yi Xue Ban · research-article; journal article · DOI 10.3785/j.issn.1008-9292.2015.05.13

Bibliografisk träff 2015-03-02

Spinal p38 activity and analgesic effect after low- and high-intensity electroacupuncture stimulation in a plantar incision rat model.

Hsu SF, Zeng YJ, Tsai SY, Chen KB, Chen JY, Chang JH, Wen YR.

Life Sci · research support, non-u.s. gov't; journal article · DOI 10.1016/j.lfs.2015.01.035

Bibliografisk träff 2015-03-01

[The effect of edaravone on MAPKs signal pathway associated with Abeta(25-35) treatment in PC12 cells].

Zhang GL, Guo YY, Zhang L, Li TT, Du Y, Yao L, Zhang WG, Wu HQ, Ma ZL.

Sichuan Da Xue Xue Bao Yi Xue Ban · journal article

Bibliografisk träff 2015-02-27

A Role for p38 Mitogen-activated Protein Kinase-mediated Threonine 30-dependent Norepinephrine Transporter Regulation in Cocaine Sensitization and Conditioned Place Preference.

Mannangatti P, NarasimhaNaidu K, Damaj MI, Ramamoorthy S, Jayanthi LD.

J Biol Chem · research support, non-u.s. gov't; research-article; journal article; research support, n.i.h., extramural · DOI 10.1074/jbc.m114.612192

Bibliografisk träff 2015-02-27

Interleukin-18 enhances breast cancer cell migration via down-regulation of claudin-12 and induction of the p38 MAPK pathway.

Yang Y, Cheon S, Jung MK, Song SB, Kim D, Kim HJ, Park H, Bang SI, Cho D.

Biochem Biophys Res Commun · research support, non-u.s. gov't; journal article · DOI 10.1016/j.bbrc.2015.02.108

Bibliografisk träff 2015-02-01

p38 MAPK inhibition alleviates experimental acute pancreatitis in mice.

Cao MH, Xu J, Cai HD, Lv ZW, Feng YJ, Li K, Chen CQ, Li YY.

Hepatobiliary Pancreat Dis Int · research support, non-u.s. gov't; journal article · DOI 10.1016/s1499-3872(15)60327-7

Bibliografisk träff 2015-02-01

Effects of p38 mitogen-activated protein kinase on osteogenic differentiation of human periodontal ligament stem cells in inflammatory microenvironment.

Nie J, Zhang B, Gu B, Liu N.

Zhongguo Yi Xue Ke Xue Yuan Xue Bao · research support, non-u.s. gov't; journal article · DOI 10.3881/j.issn.1000-503x.2015.01.001

Bibliografisk träff 2015-01-01

Vasoconstrictive effect of tenascin-C on cerebral arteries in rats.

Fujimoto M, Shiba M, Kawakita F, Shimojo N, Imanaka-Yoshida K, Yoshida T, Kanamaru K, Taki W, Suzuki H.

Acta Neurochir Suppl · research support, non-u.s. gov't; journal article · DOI 10.1007/978-3-319-04981-6_17

Bibliografisk träff 2014-12-08

EPO gene expression promotes proliferation, migration and invasion via the p38MAPK/AP-1/MMP-9 pathway by p21WAF1 expression in vascular smooth muscle cells.

Park SL, Won SY, Song JH, Kambe T, Nagao M, Kim WJ, Moon SK.

Cell Signal · research support, non-u.s. gov't; journal article · DOI 10.1016/j.cellsig.2014.12.001

Bibliografisk träff 2014-11-28

Rho-kinase regulates human platelet activation induced by thromboxane A2 independently of p38 MAP kinase.

Iida Y, Doi T, Tokuda H, Matsushima-Nishiwaki R, Tsujimoto M, Kuroyanagi G, Yamamoto N, Enomoto Y, Tanabe K, Otsuka T, Iwama T, Ogura S, Kozawa O, Iida H.

Prostaglandins Leukot Essent Fatty Acids · research support, non-u.s. gov't; journal article · DOI 10.1016/j.plefa.2014.11.006

Bibliografisk träff 2014-11-13

Role of p38 MAPK pathway in 17β-estradiol-mediated attenuation of hemorrhagic shock-induced hepatic injury.

Hsu JT, Chen TH, Chiang KC, Kuo CJ, Lin CJ, Yeh TS.

J Appl Physiol (1985) · research support, non-u.s. gov't; journal article · DOI 10.1152/japplphysiol.00464.2014

Bibliografisk träff 2014-10-30

Mechanism of tissue factor production by monocytes stimulated with neutrophil elastase.

Kawata J, Aoki M, Ishimaru Y, Ono T, Sagara K, Narahara S, Matsmoto T, Hirose E, Yamaguchi Y.

Blood Cells Mol Dis · journal article · DOI 10.1016/j.bcmd.2014.10.005

Bibliografisk träff 2014-09-19

Functional characterization of receptor-interacting serine/threonine kinase 2 (RIP2) of the goldfish (Carassius auratus L.).

Xie J, Belosevic M.

Dev Comp Immunol · research support, non-u.s. gov't; journal article · DOI 10.1016/j.dci.2014.09.006

Bibliografisk träff 2014-08-30

P38 MAPK inhibition protects against glutamate neurotoxicity and modifies NMDA and AMPA receptor subunit expression.

Rivera-Cervantes MC, Castañeda-Arellano R, Castro-Torres RD, Gudiño-Cabrera G, Gudiño-Cabrera G, Feria y Velasco AI, Camins A, Beas-Zárate C.

J Mol Neurosci · research support, non-u.s. gov't; journal article · DOI 10.1007/s12031-014-0398-0

Bibliografisk träff 2014-01-01

Effect of SB203580 on pathologic change of pancreatic tissue and expression of TNF-α and IL-1β in rats with severe acute pancreatitis.

Wang XY, Tang QQ, Zhang JL, Fang MY, Li YX.

Eur Rev Med Pharmacol Sci · research support, non-u.s. gov't; journal article

Bibliografisk träff 2012-02-20

Novel protein kinase signaling systems regulating lifespan identified by small molecule library screening using Drosophila.

Spindler SR, Li R, Dhahbi JM, Yamakawa A, Sauer F.

PLoS One · research support, non-u.s. gov't; research-article; journal article · DOI 10.1371/journal.pone.0029782

Bibliografisk träff 2009-03-01

Non-specific in vivo inhibition of CK1 by the pyridinyl imidazole p38 inhibitors SB 203580 and SB 202190.

Shanware NP, Williams LM, Bowler MJ, Tibbetts RS.

BMB Rep · research support, non-u.s. gov't; research-article; journal article; research support, n.i.h., extramural · DOI 10.5483/bmbrep.2009.42.3.142

Bibliografisk träff 2005-02-04

Temporary blockade of contractility during reperfusion elicits a cardioprotective effect of the p38 MAP kinase inhibitor SB-203580.

Sumida T, Otani H, Kyoi S, Okada T, Fujiwara H, Nakao Y, Kido M, Imamura H.

Am J Physiol Heart Circ Physiol · research support, non-u.s. gov't; journal article · DOI 10.1152/ajpheart.01183.2004

Bibliografisk träff 2002-04-01

Dichotomal role of inhibition of p38 MAPK with SB 203580 in experimental colitis.

ten Hove T, van den Blink B, Pronk I, Drillenburg P, Peppelenbosch MP, van Deventer SJ.

Gut · research-article; journal article · DOI 10.1136/gut.50.4.507

Bibliografisk träff 2001-08-01

SB203580, a specific inhibitor of p38-MAPK pathway, is a new reversal agent of P-glycoprotein-mediated multidrug resistance.

Barancík M, Bohácová V, Kvackajová J, Hudecová S, Krizanová O, Breier A.

Eur J Pharm Sci · research support, non-u.s. gov't; journal article · DOI 10.1016/s0928-0987(01)00139-7

Bibliografisk träff 2000-12-01

SB 203580, an inhibitor of p38 MAPK, abolishes infarct-limiting effect of ischemic preconditioning in isolated rabbit hearts.

Nakano A, Cohen MV, Critz S, Downey JM.

Basic Res Cardiol · research support, u.s. gov't, p.h.s.; journal article · DOI 10.1007/s003950070022

Bibliografisk träff 1998-10-01

Direct inhibition of cyclooxygenase-1 and -2 by the kinase inhibitors SB 203580 and PD 98059. SB 203580 also inhibits thromboxane synthase.

Börsch-Haubold AG, Pasquet S, Watson SP.

J Biol Chem · research support, non-u.s. gov't; journal article · DOI 10.1074/jbc.273.44.28766